A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
← catalyst calendarSponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
101actual
Sites
43
Countries
Argentina, Belgium, Czechia +9
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-04-13 | actual | When the study began enrolling |
| Primary completion | 2024-02-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jan 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2020-08-26 | actual | When this record first appeared on the registry |
| Results posted | 2025-06-05 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Juvenile Psoriatic Arthritis
- Enthesitis Related Arthritis
Interventions
- Drug: Ixekizumab — also filed as LY2439821
- Drug: Adalimumab
Primary outcome
what the primary-completion date above is the date OFPercentage of Participants Achieving Juvenile Idiopathic Arthritis (JIA) American College of Rheumatology (ACR) 30 (Ixekizumab - OLT Period)
measured Week 16
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2023-12-01 · 2.2 MB · Prot_000.pdf
Statistical Analysis Planposted 2024-03-12 · 17.0 MB · SAP_001.pdf
Publications
- PMID 41785908 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed